| 000 | 01050 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514055552.0 | ||
| 264 | 0 | _c20030701 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a1471-4892 | ||
| 024 | 7 |
_a10.1016/s1471-4892(02)00011-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrotchie, Jonathan M | |
| 245 | 0 | 0 |
_aCB1 cannabinoid receptor signalling in Parkinson's disease. _h[electronic resource] |
| 260 |
_bCurrent opinion in pharmacology _cFeb 2003 |
||
| 300 |
_a54-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasal Ganglia _xdrug effects |
| 650 | 0 | 4 | _aCannabinoid Receptor Modulators |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aReceptors, Cannabinoid |
| 650 | 0 | 4 |
_aReceptors, Drug _xagonists |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 773 | 0 |
_tCurrent opinion in pharmacology _gvol. 3 _gno. 1 _gp. 54-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1471-4892(02)00011-5 _zAvailable from publisher's website |
| 999 |
_c12351100 _d12351100 |
||